細胞療法処理の世界市場と技術

Report Highlights

The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.

Report Includes

• 32 data tables and 58 additional tables
• An overview of the global market and technologies for cell therapy processing
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to the cell therapy processing, accompanied by a market share analysis by offerings, application and region
• Analysis of current and future demand in the global cell therapy processing market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges and opportunities affecting market growth
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
• Market share analysis of the key market participants in the cell therapy processing market, along with their research priorities, product portfolios, global rankings and company competitive landscape
• Profiles of the major companies, including Thermo Fisher Scientific Inc., Danaher Corp., Lonza, Miltenyi Biotech and Sartorius AG

Report Scope

The report provides an overview of global cell therapy processing and analyzes market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025 with forecasts through 2030. The market is segmented based on offering type, application and regions. By offering, the market is segmented into products, software and services. By application, the market is segmented into cancer, musculoskeletal disorders, neurological disorders, cardiovascular diseases and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East, Africa, and South America, focusing on the major countries in these regions. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, and the Rest of Asia-Pacific.

The report focuses on the significant driving trends and challenges that affect the market. It analyzes environmental, social and corporate governance (ESG) developments. It includes an analysis of the competitive landscape and has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Market Insights
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Overview
Cell Therapy Manufacturing Process
Cell Therapy Supply Chain
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of U.S. Tariffs
Porter’s Five Forces Analysis
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Growing Demand for Regenerative Medicine
Increasing Investments in Cell and Gene Therapy (CGT) Research
Expanding Clinical and Commercial Activities
Growing Number of Strategic Initiatives
Rising Aging Population and the Increasing Prevalence of Chronic Diseases
Market Restraints
Complex Manufacturing and Supply Chain
High Cost of Development
Lack of Skilled Workforce
Regulatory Hurdles
Market Opportunities
Decentralized Manufacturing
Shift Toward Allogeneic Therapies
Chapter 4 Regulatory Landscape
Overview
Regulatory Scenario by Country/Region
U.S. FDA
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Key Takeaways
Automation
First-Generation Automated Platforms
Second-Generation Automated Platforms
Single-Use Technologies and Miniaturization
Chapter 6 Market Segment Analysis
Overview
Segmentation Breakdown
Market Analysis by Type of Offerings
Key Takeaways
Products
Services
Software
Market Analysis by Application
Key Takeaways
Cancer
Musculoskeletal Disorders (Bone and Skeletal Muscle Repair)
Neurological Disorders
Cardiovascular Disorders
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Agreements, Collaborations and Partnerships
Acquisitions
Investments and Expansions
Chapter 8 Sustainability in Cell Therapy Processing Market: An ESG Perspective
Introduction to ESG
Sustainability in the Cell Therapy Processing Industry
Environmental Factors
Social Factors
Governance Factors
ESG Sustainability Trends and Initiatives
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks
Chapter 9 Appendix
Research Methodology
Information Sources
Abbreviations
Company Profiles
BIO-TECHNE
BIOSPHERIX LLC.
CYTIVA
FRESENIUS KABI AG
FUJIFILM BIOSCIENCES
LONZA
MERCK KGAA
MILTENYI BIOTEC
PROTEINTECH GROUP INC.
REVVITY
SARTORIUS AG
STEMCELL TECHNOLOGIES
TERUMO CORP.
THERMO FISHER SCIENTIFIC INC.
THERMOGENESIS
Emerging Start-ups/Market Disruptors

List of Tables

List of Tables
Summary Table : Global Market for Cell Therapy Processing, by Region, Through 2030
Table 1 : Classification of Stem Cells
Table 2 : Incidence and Mortality Rates of Cancer Across Regions, 2022
Table 3 : Comparison Between Autologous and Allogeneic Therapeutics
Table 4 : Regulations for Advanced Therapies in the Asia-Pacific Region
Table 5 : Global Market for Cell Therapy Processing, by Offering, Through 2030
Table 6 : Global Market for Cell Therapy Processing Products, by Region, Through 2030
Table 7 : Global Market for Cell Therapy Processing Services, by Region, Through 2030
Table 8 : Global Market for Cell Therapy Processing Software, by Region, Through 2030
Table 9 : Global Market for Cell Therapy Processing, by Application, Through 2030
Table 10 : Global Market for Cell Therapy Processing for Oncology, by Region, Through 2030
Table 11 : Global Market for Cell Therapy Processing for Musculoskeletal Disorders, by Region, Through 2030
Table 12 : Global Market for Cell Therapy Processing for Neurological Disorders, by Region, Through 2030
Table 13 : Global Market for Cell Therapy Processing for Cardiovascular Disorders, by Region, Through 2030
Table 14 : Global Market for Cell Therapy Processing for Other Disease Indications, by Region, Through 2030
Table 15 : Global Market for Cell Therapy Processing, by Region, Through 2030
Table 16 : North American Market for Cell Therapy Processing, by Offering, Through 2030
Table 17 : North American Market for Cell Therapy Processing, by Application, Through 2030
Table 18 : North American Market for Cell Therapy Processing, by Country, Through 2030
Table 19 : European Market for Cell Therapy Processing, by Offering, Through 2030
Table 20 : European Market for Cell Therapy Processing, by Application, Through 2030
Table 21 : European Market for Cell Therapy Processing, by Country, Through 2030
Table 22 : Asia-Pacific Market for Cell Therapy Processing, by Offering, Through 2030
Table 23 : Asia-Pacific Market for Cell Therapy Processing, by Application, Through 2030
Table 24 : Asia-Pacific Market for Cell Therapy Processing, by Country, Through 2030
Table 25 : RoW Market for Cell Therapy Processing, by Offering, Through 2030
Table 26 : RoW Market for Cell Therapy Processing, by Application, Through 2030
Table 27 : RoW Market for Cell Therapy Processing, by Sub-Region, Through 2030
Table 28 : Global Ranking of Players: Cell Therapy Processing Market, 2024
Table 29 : Agreements, Collaborations and Partnerships: Cell Therapy Processing Market, 2021–2025
Table 30 : Acquisitions: Cell Therapy Processing Market, 2022–2025
Table 31 : VC Investments and Expansion Activities: Cell Therapy Processing Market, 2022–2025
Table 32 : ESG: Environmental Overview
Table 33 : ESG: Social Overview
Table 34 : ESG: Governance Overview
Table 35 : ESG Risk Rankings for Cell Therapy Processing Market Companies, 2025
Table 36 : Information Sources in this Report
Table 37 : Abbreviations Used in the Cell Therapy Processing Market Report
Table 38 : Bio-Techne: Company Snapshot
Table 39 : Bio-Techne: Financial Performance, FY 2023 and 2024
Table 40 : Bio-Techne: Product Portfolio
Table 41 : Bio-Techne: News/Key Developments, 2022–2025
Table 42 : BioSpherix LLC.: Company Snapshot
Table 43 : BioSpherix LLC.: Product Portfolio
Table 44 : BioSpherix LLC.: News/Key Developments, 2022–2025
Table 45 : Cytiva.: Company Snapshot
Table 46 : Cytiva: Product Portfolio
Table 47 : Cytiva: News/Key Developments, 2021–2024
Table 48 : Fresenius Kabi AG: Company Snapshot
Table 49 : Fresenius Kabi AG: Financial Performance, FY 2023 and 2024
Table 50 : Fresenius Kabi AG: Product Portfolio
Table 51 : Fresenius Kabi AG: News/Key Developments, 2022–2024
Table 52 : Fujifilm Biosciences: Company Snapshot
Table 53 : Fujifilm Biosciences: Product Portfolio
Table 54 : Fujifilm Biosciences: News/Key Developments, 2022–2025
Table 55 : Lonza: Company Snapshot
Table 56 : Lonza: Financial Performance, FY 2023 and 2024
Table 57 : Lonza: Product Portfolio
Table 58 : Lonza: News/Key Developments, 2021–2024
Table 59 : Merck KGaA: Company Snapshot
Table 60 : Merck KGaA.: Financial Performance, FY 2023 and 2024
Table 61 : Merck KGaA: Product Portfolio
Table 62 : Merck KGaA.: News/Key Developments, 2021–2025
Table 63 : Miltenyi Biotec: Company Snapshot
Table 64 : Miltenyi Biotec: Product Portfolio
Table 65 : Miltenyi Biotec: News/Key Developments, 2023–2024
Table 66 : Proteintech Group Inc.: Company Snapshot
Table 67 : Proteintech Group Inc.: Product Portfolio
Table 68 : Revvity: Company Snapshot
Table 69 : Revvity: Financial Performance, FY 2023 and 2024
Table 70 : Revvity: Product Portfolio
Table 71 : Revvity: News/Key Developments, 2024 and 2025
Table 72 : Sartorius AG: Company Snapshot
Table 73 : Sartorius AG: Financial Performance, FY 2023 and 2024
Table 74 : Sartorius AG: Product Portfolio
Table 75 : Sartorius AG: News/Key Developments, 2023–2024
Table 76 : STEMCELL Technologies: Company Snapshot
Table 77 : STEMCELL Technologies: Product Portfolio
Table 78 : STEMCELL Technologies: News/Key Developments, 2022–2025
Table 79 : Terumo Corp.: Company Snapshot
Table 80 : Terumo Corp.: Financial Performance, FY 2023 and 2024
Table 81 : Terumo Corp.: Product Portfolio
Table 82 : Terumo Corp.: News/Key Developments, 2021–2025
Table 83 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 84 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 85 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 86 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022–2025
Table 87 : ThermoGenesis: Company Snapshot
Table 88 : ThermoGenesis: Product Portfolio
Table 89 : List of a Few Emerging Startups in the Cell Therapy Processing Market

List of Figures

List of Figures
Summary Figure : Global Market Shares of Cell Therapy Processing, by Region, 2024
Figure 1 : Porter’s Five Forces Analysis of the Cell Therapy Processing Market
Figure 2 : Snapshot of the Market Dynamics for Cell Therapy Processing
Figure 3 : CGT Market Investments, by Year, 2019–2024
Figure 4 : CGT Market Investments, by Deal Type, H1 2025
Figure 5 : Global Market Shares of Cell Therapy Processing, by Offering Type, 2024
Figure 6 : Global Market Shares of Cell Therapy Processing, by Application, 2024
Figure 7 : Global Market Shares of Cell Therapy Processing, by Region, 2024
Figure 8 : North American Market Shares of Cell Therapy Processing, by Country, 2024
Figure 9 : European Market Shares of Cell Therapy Processing, by Country, 2024
Figure 10 : Asia-Pacific Market Shares of Cell Therapy Processing, by Country, 2024
Figure 11 : RoW Market Shares of Cell Therapy Processing, by Sub-Region, 2024
Figure 12 : Bio-Techne: Revenue Share, by Business Unit, FY 2024
Figure 13 : Bio-Techne: Revenue Share, by Country/Region, FY 2024
Figure 14 : Fresenius Kabi AG: Revenue Share, by Business Unit, FY 2024
Figure 15 : Lonza: Revenue Share, by Business Unit, FY 2024
Figure 16 : Lonza: Revenue Share, by Country/Region, FY 2024
Figure 17 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
Figure 18 : Merck KGaA.: Revenue Share by Country/Region, FY 2024
Figure 19 : Revvity: Revenue Share, by Business Unit, FY 2024
Figure 20 : Revvity: Revenue Share, by Country/Region, FY 2024
Figure 21 : Sartorius AG: Revenue Share, by Business Unit, FY 2024
Figure 22 : Sartorius AG: Revenue Share, by Country/Region, FY 2024
Figure 23 : Terumo Corp.: Revenue Share, by Business Unit, FY 2024
Figure 24 : Terumo Corp.: Revenue Share, by Country/Region, FY 2024
Figure 25 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 26 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧